PL2925293T3 - Formulacje tetracykliny do stosowania miejscowego, ich przygotowanie i zastosowania - Google Patents
Formulacje tetracykliny do stosowania miejscowego, ich przygotowanie i zastosowaniaInfo
- Publication number
- PL2925293T3 PL2925293T3 PL13792728T PL13792728T PL2925293T3 PL 2925293 T3 PL2925293 T3 PL 2925293T3 PL 13792728 T PL13792728 T PL 13792728T PL 13792728 T PL13792728 T PL 13792728T PL 2925293 T3 PL2925293 T3 PL 2925293T3
- Authority
- PL
- Poland
- Prior art keywords
- preparation
- application
- local use
- tetracycline formulations
- tetracycline
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/203—Retinoic acids ; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4436—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Ophthalmology & Optometry (AREA)
- Dispersion Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PT106679A PT106679B (pt) | 2012-11-27 | 2012-11-27 | Formulações tópicas de tetraciclinas, sua preparação e usos |
| PCT/GB2013/052939 WO2014083311A1 (en) | 2012-11-27 | 2013-11-08 | Tetracycline topical formulations, preparation and uses thereof |
| EP13792728.1A EP2925293B1 (en) | 2012-11-27 | 2013-11-08 | Tetracycline topical formulations, preparation and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2925293T3 true PL2925293T3 (pl) | 2017-12-29 |
Family
ID=49620233
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL13792728T PL2925293T3 (pl) | 2012-11-27 | 2013-11-08 | Formulacje tetracykliny do stosowania miejscowego, ich przygotowanie i zastosowania |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US9592246B2 (pl) |
| EP (1) | EP2925293B1 (pl) |
| JP (1) | JP6444308B2 (pl) |
| KR (1) | KR102235922B1 (pl) |
| CN (1) | CN104902875B (pl) |
| AU (1) | AU2013350941B2 (pl) |
| BR (1) | BR112015012162B1 (pl) |
| CA (1) | CA2895395C (pl) |
| DK (1) | DK2925293T3 (pl) |
| ES (1) | ES2645449T3 (pl) |
| HU (1) | HUE034932T2 (pl) |
| IL (1) | IL239022B (pl) |
| MX (1) | MX355174B (pl) |
| NO (1) | NO2925293T3 (pl) |
| NZ (1) | NZ708824A (pl) |
| PL (1) | PL2925293T3 (pl) |
| PT (1) | PT106679B (pl) |
| RU (1) | RU2639591C2 (pl) |
| SG (1) | SG11201504145PA (pl) |
| WO (1) | WO2014083311A1 (pl) |
| ZA (1) | ZA201504369B (pl) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL152486A0 (en) | 2002-10-25 | 2003-05-29 | Meir Eini | Alcohol-free cosmetic and pharmaceutical foam carrier |
| US9211259B2 (en) | 2002-11-29 | 2015-12-15 | Foamix Pharmaceuticals Ltd. | Antibiotic kit and composition and uses thereof |
| US7700076B2 (en) | 2002-10-25 | 2010-04-20 | Foamix, Ltd. | Penetrating pharmaceutical foam |
| JP2006505583A (ja) | 2002-10-25 | 2006-02-16 | フォーミックス エルティーディー． | 化粧剤および医薬用フォーム |
| US7704518B2 (en) | 2003-08-04 | 2010-04-27 | Foamix, Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
| US20080138296A1 (en) | 2002-10-25 | 2008-06-12 | Foamix Ltd. | Foam prepared from nanoemulsions and uses |
| US10117812B2 (en) | 2002-10-25 | 2018-11-06 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
| US9265725B2 (en) | 2002-10-25 | 2016-02-23 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
| US9668972B2 (en) | 2002-10-25 | 2017-06-06 | Foamix Pharmaceuticals Ltd. | Nonsteroidal immunomodulating kit and composition and uses thereof |
| US20080260655A1 (en) | 2006-11-14 | 2008-10-23 | Dov Tamarkin | Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
| US8636982B2 (en) | 2007-08-07 | 2014-01-28 | Foamix Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
| US9439857B2 (en) | 2007-11-30 | 2016-09-13 | Foamix Pharmaceuticals Ltd. | Foam containing benzoyl peroxide |
| WO2009072007A2 (en) | 2007-12-07 | 2009-06-11 | Foamix Ltd. | Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof |
| WO2010125470A2 (en) | 2009-04-28 | 2010-11-04 | Foamix Ltd. | Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
| CA2769625C (en) | 2009-07-29 | 2017-04-11 | Foamix Ltd. | Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses |
| CA2769677A1 (en) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses |
| MX359879B (es) | 2009-10-02 | 2018-10-12 | Foamix Pharmaceuticals Ltd | Composiciones tópicas de tetraciclina. |
| US9849142B2 (en) | 2009-10-02 | 2017-12-26 | Foamix Pharmaceuticals Ltd. | Methods for accelerated return of skin integrity and for the treatment of impetigo |
| US20180228811A1 (en) * | 2014-12-12 | 2018-08-16 | The Schepens Eye Research Institute, Inc. | Gdnf induction for the treatment of retinal disorders |
| JP2018506554A (ja) * | 2015-02-25 | 2018-03-08 | サン、ファーマ、アドバンスト、リサーチ、カンパニー、リミテッドＳｕｎ Ｐｈａｒｍａ Ａｄｖａｎｃｅｄ Ｒｅｓｅａｒｃｈ Ｃｏｍｐａｎｙ Ｌｉｍｉｔｅｄ | ナノ粒子組成物 |
| KR20170134514A (ko) | 2015-03-23 | 2017-12-06 | 바이오팜엑스 인코포레이티드 | 피부과 사용을 위한 약학 테트라사이클린 조성물 |
| CN105380900B (zh) * | 2015-11-25 | 2018-05-29 | 徐州医学院 | 一种治疗痤疮的纳米磁疗外用凝胶及其制备方法和应用 |
| MX377365B (es) | 2016-09-08 | 2025-03-10 | Journey Medical Corp | Composiciones y métodos para tratar rosácea y acné. |
| FR3064482B1 (fr) * | 2017-04-03 | 2020-11-13 | Horus Pharma | Composition topique de doxycycline |
| JP2021500369A (ja) * | 2017-10-24 | 2021-01-07 | グレンマーク・ファーマシューティカルズ・リミテッド | アダパレン及びミノサイクリンの局所用医薬組成物 |
| WO2019106036A1 (en) | 2017-11-28 | 2019-06-06 | C-Lecta Gmbh | Method for producing trehalose employing a trehalose phosphorylase variant |
| BR112020013789A2 (pt) | 2018-01-07 | 2021-02-17 | Dr. Reddy's Laboratories Ltd. | métodos para o tratamento de afecções cutâneas inflamatórias |
| US11202788B2 (en) | 2019-08-22 | 2021-12-21 | Nanopharmaceutics, Inc. | Topical doxycycline hydrogel with improved long-term stability |
| WO2021191273A1 (en) | 2020-03-24 | 2021-09-30 | Hovione Scientia Limited | Compositions for use in treating meibomian gland dysfunction |
| WO2022043457A1 (en) | 2020-08-27 | 2022-03-03 | Hovione Scientia Limited | Methods and compositions for treating rosacea |
| WO2022090302A1 (en) * | 2020-10-28 | 2022-05-05 | Hovione Scientia Limited | Methods and compositions for treating meibomian gland dysfunction, dry eye disease, and related disorders |
| CN115463091B (zh) * | 2022-10-27 | 2023-04-07 | 新基元(北京)医药科技有限公司 | 一种改善稳定性的米诺环素泡沫剂 |
Family Cites Families (65)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB769274A (en) * | 1954-04-22 | 1957-03-06 | Pfizer | Therapeutic preparations of tetracycline antibiotics in oil |
| GB1581335A (en) | 1976-07-05 | 1980-12-10 | Leo Pharm Prod Ltd | 16-s-acyl derivatives of fusidic acid |
| US4505896A (en) | 1979-04-19 | 1985-03-19 | Elorac, Ltd. | Method of treating acne vulgaris and composition |
| JPS5788115A (en) * | 1980-10-06 | 1982-06-01 | Miles Lab | Stable non-aqueous solution of tetracycline antibiotic salt |
| US5122519A (en) | 1989-06-27 | 1992-06-16 | American Cyanamid Company | Stable, cosmetically acceptable topical gel formulation and method of treatment for acne |
| US5874479A (en) | 1991-03-01 | 1999-02-23 | Warner-Lambert Company | Therapeutic permeation enhanced-wound healing compositions and methods for preparing and using same |
| US6113921A (en) | 1993-03-23 | 2000-09-05 | Pharmos Corp. | Topical and transdermal delivery system utilizing submicron oil spheres |
| US5905092A (en) | 1994-09-27 | 1999-05-18 | Virotex Corporation Reel/Frame | Topical antibiotic composition providing optimal moisture environment for rapid wound healing that reduces skin contraction |
| US5747058A (en) | 1995-06-07 | 1998-05-05 | Southern Biosystems, Inc. | High viscosity liquid controlled delivery system |
| WO1997029733A1 (en) * | 1996-02-16 | 1997-08-21 | Janssen Pharmaceutica N.V. | Compositions containing an antifungal and a sulfur compound |
| JPH09255578A (ja) * | 1996-03-22 | 1997-09-30 | Sekisui Chem Co Ltd | 感染性皮膚疾患治療用外用剤 |
| US5834008A (en) | 1996-09-19 | 1998-11-10 | U.S. Biomaterials Corp. | Composition and method for acceleration of wound and burn healing |
| US6433068B1 (en) * | 1997-03-07 | 2002-08-13 | David S. Morrison | Hydrocarbon gels as suspending and dispersing agents and products |
| WO1999058131A1 (en) * | 1998-05-08 | 1999-11-18 | University Of Miami | Use of tetracyclines for treating meibomian gland disease |
| US20030007939A1 (en) | 1998-07-31 | 2003-01-09 | Howard Murad | Pharmaceutical compositions and methods for managing dermatological conditions |
| US6432934B1 (en) * | 1998-08-06 | 2002-08-13 | Advanced Vision Research | Methods and compositions for topical treatment of eye surface inflammation and related dry eye disease |
| CN1320046A (zh) * | 1999-07-12 | 2001-10-31 | 三得利株式会社 | 局部给药的药用组合物 |
| US6946118B1 (en) | 1999-09-14 | 2005-09-20 | Orapharma, Inc. | Formulations for treating or preventing mucositis |
| US6667045B2 (en) | 1999-10-01 | 2003-12-23 | Joseph Scott Dahle | Topical applications for skin treatment |
| US20030077301A1 (en) | 1999-12-16 | 2003-04-24 | Maibach Howard I. | Topical pharmaceutical composition for the treatment of inflammatory dermatoses |
| US6967023B1 (en) | 2000-01-10 | 2005-11-22 | Foamix, Ltd. | Pharmaceutical and cosmetic carrier or composition for topical application |
| US20020010162A1 (en) | 2000-03-02 | 2002-01-24 | Raul Fleischmajer | Treatment of psoriasis with matrix metalloproteinase inhibitors |
| US7758888B2 (en) | 2000-04-21 | 2010-07-20 | Sol-Gel Technologies Ltd. | Composition exhibiting enhanced formulation stability and delivery of topical active ingredients |
| JP4653282B2 (ja) * | 2000-05-23 | 2011-03-16 | 昭和薬品化工株式会社 | ミノサイクリン含有組成物 |
| US8512718B2 (en) | 2000-07-03 | 2013-08-20 | Foamix Ltd. | Pharmaceutical composition for topical application |
| CA2447008A1 (en) * | 2001-04-05 | 2002-10-24 | Collagenex Pharmaceuticals, Inc. | Controlled delivery of tetracycline compounds and tetracycline derivatives |
| JP4745608B2 (ja) | 2001-07-27 | 2011-08-10 | バイタル ヘルス サイエンシズ プロプライアタリー リミティド | 電子伝達剤のリン酸誘導体を用いた皮膚治療 |
| ES2364269T3 (es) | 2002-06-17 | 2011-08-30 | Naicons S.C.A.R.L. | Uso de derivado de amida de ge 2270 factor a3 para el tratamiento del acné. |
| US20040076699A1 (en) * | 2002-07-15 | 2004-04-22 | Chaudhuri Ratan K. | Topical anhydrous delivery system |
| US7700076B2 (en) | 2002-10-25 | 2010-04-20 | Foamix, Ltd. | Penetrating pharmaceutical foam |
| US7820145B2 (en) | 2003-08-04 | 2010-10-26 | Foamix Ltd. | Oleaginous pharmaceutical and cosmetic foam |
| US7704518B2 (en) * | 2003-08-04 | 2010-04-27 | Foamix, Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
| US7575739B2 (en) | 2003-04-28 | 2009-08-18 | Foamix Ltd. | Foamable iodine composition |
| MXPA05013213A (es) | 2003-06-11 | 2006-03-09 | Procter & Gamble | Dispositivo para preparar un producto en el momento de usarlo que comprende un producto de hidrogel preformado. |
| US8486374B2 (en) | 2003-08-04 | 2013-07-16 | Foamix Ltd. | Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses |
| US7241746B2 (en) | 2003-08-06 | 2007-07-10 | Regena Therapeutics, Lc | Method and composition for treating periodontal disease |
| DK1791791T3 (da) | 2004-09-27 | 2019-08-26 | Special Water Patents B V | Fremgangsmåder og sammensætninger til behandling af vand |
| US7531164B2 (en) | 2005-10-21 | 2009-05-12 | Duke University | Preventing bacterial or viral infectivity and composition containing infection preventing additive |
| GB2432529B (en) | 2005-11-25 | 2008-04-23 | Univ Feng Chia | Antimicrobial compositions and wound dressings |
| JP4959991B2 (ja) * | 2006-03-03 | 2012-06-27 | 株式会社日本点眼薬研究所 | トラニラストまたはその薬理学的に許容される塩を含有する懸濁性医薬組成物 |
| WO2008097850A1 (en) | 2007-02-02 | 2008-08-14 | Warner Chilcott Company, Inc. | Tretracycline compositions for topical administration |
| WO2008097851A1 (en) | 2007-02-02 | 2008-08-14 | Warner Chilcott Company, Inc. | Tetracycline compositions for topical administration |
| JP2010520210A (ja) | 2007-02-28 | 2010-06-10 | アーシエックス セラピューティックス， インコーポレイテッド | マイボーム腺分泌を正常化するための方法および組成物 |
| CN102688492A (zh) * | 2007-03-23 | 2012-09-26 | 分子研究中心公司 | 包含四环素类的抗炎组合物及其用途 |
| DK2079441T3 (da) | 2007-07-25 | 2010-12-13 | Ixodes Gmbh | Topisk antibiotisk sammensætning til forebyggelse af Lyme's sygdom |
| WO2009072007A2 (en) | 2007-12-07 | 2009-06-11 | Foamix Ltd. | Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof |
| US8518376B2 (en) | 2007-12-07 | 2013-08-27 | Foamix Ltd. | Oil-based foamable carriers and formulations |
| GB0800145D0 (en) * | 2008-01-04 | 2008-02-13 | Reckitt Benckiser Uk Ltd | Skincare treatment |
| EP2266626B1 (en) * | 2008-03-28 | 2014-06-18 | AnGesMG, Inc. | Composition for external application comprising transcription factor decoy as active ingredient |
| CN102083406A (zh) * | 2008-04-29 | 2011-06-01 | 毛发系统公司 | 用于漂白膏产品的组合物和方法 |
| US20100029765A1 (en) | 2008-07-30 | 2010-02-04 | Ranbaxy Labortories Limited | Topical aqueous composition comprising tretinoin |
| CA2734687A1 (en) * | 2008-08-18 | 2010-02-25 | Nanotherapeutics, Inc. | Topical hydrogel composition |
| WO2010125470A2 (en) | 2009-04-28 | 2010-11-04 | Foamix Ltd. | Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
| PT104644B (pt) | 2009-06-26 | 2012-11-06 | Hovione Farmaciencia S A | Formulação tópica contendo uma tetraciclina e método de tratamento de infecções cutâneas usando a mesma |
| US9155915B2 (en) | 2009-07-27 | 2015-10-13 | Dermadoctor, Inc. | Moisturizing retinol composition |
| WO2011138678A2 (en) * | 2010-05-04 | 2011-11-10 | Foamix Ltd. | Compositions, gels and foams with rheology modulators and uses thereof |
| GB2474930B (en) * | 2009-10-02 | 2012-07-04 | Foamix Ltd | Topical tetracycline compositions |
| MX359879B (es) | 2009-10-02 | 2018-10-12 | Foamix Pharmaceuticals Ltd | Composiciones tópicas de tetraciclina. |
| EP2538965B1 (en) | 2010-02-25 | 2017-04-12 | Schepens Eye Research Institute | Therapeutic compositions for the treatment of dry eye disease |
| US20120076742A1 (en) | 2010-04-21 | 2012-03-29 | Phillips D Howard | Topical drug delivery system with dual carriers |
| PT105116B (pt) | 2010-05-14 | 2012-10-16 | Hovione Farmaciencia S A | Novas partículas de tetraciclina e agente protector. |
| BRPI1002601E2 (pt) | 2010-06-01 | 2020-06-30 | Embrapa Pesquisa Agropecuaria | composição nanoestruturada de uso veterinário para administração de fármacos |
| US20120093876A1 (en) | 2010-10-13 | 2012-04-19 | Aciex, Inc. | Ophthalmic Formulations, Methods Of Manufacture And Methods of Normalizing Meibomian Gland Secretions |
| CA2719512A1 (en) | 2010-11-01 | 2012-05-01 | Stiefel Research Australia Pty Ltd | Polymeric topical compositions |
| JP2014503586A (ja) | 2011-01-24 | 2014-02-13 | アンテリオス， インコーポレイテッド | 油組成物 |
-
2012
- 2012-11-27 PT PT106679A patent/PT106679B/pt active IP Right Grant
-
2013
- 2013-11-08 BR BR112015012162-4A patent/BR112015012162B1/pt active IP Right Grant
- 2013-11-08 RU RU2015122786A patent/RU2639591C2/ru active
- 2013-11-08 EP EP13792728.1A patent/EP2925293B1/en active Active
- 2013-11-08 SG SG11201504145PA patent/SG11201504145PA/en unknown
- 2013-11-08 ES ES13792728.1T patent/ES2645449T3/es active Active
- 2013-11-08 CN CN201380068453.1A patent/CN104902875B/zh active Active
- 2013-11-08 JP JP2015543515A patent/JP6444308B2/ja active Active
- 2013-11-08 MX MX2015006632A patent/MX355174B/es active IP Right Grant
- 2013-11-08 PL PL13792728T patent/PL2925293T3/pl unknown
- 2013-11-08 WO PCT/GB2013/052939 patent/WO2014083311A1/en not_active Ceased
- 2013-11-08 US US14/074,868 patent/US9592246B2/en active Active - Reinstated
- 2013-11-08 NO NO13792728A patent/NO2925293T3/no unknown
- 2013-11-08 NZ NZ708824A patent/NZ708824A/en not_active IP Right Cessation
- 2013-11-08 KR KR1020157017068A patent/KR102235922B1/ko active Active
- 2013-11-08 AU AU2013350941A patent/AU2013350941B2/en not_active Ceased
- 2013-11-08 HU HUE13792728A patent/HUE034932T2/en unknown
- 2013-11-08 CA CA2895395A patent/CA2895395C/en active Active
- 2013-11-08 DK DK13792728.1T patent/DK2925293T3/da active
-
2015
- 2015-05-26 IL IL239022A patent/IL239022B/en active IP Right Grant
- 2015-06-17 ZA ZA2015/04369A patent/ZA201504369B/en unknown
-
2017
- 2017-03-13 US US15/457,809 patent/US10213443B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| HUE034932T2 (en) | 2018-03-28 |
| PT106679A (pt) | 2014-05-27 |
| WO2014083311A1 (en) | 2014-06-05 |
| PT106679B (pt) | 2015-03-25 |
| AU2013350941A1 (en) | 2015-07-16 |
| CA2895395A1 (en) | 2014-06-05 |
| MX2015006632A (es) | 2016-02-17 |
| MX355174B (es) | 2018-04-09 |
| NO2925293T3 (pl) | 2017-12-30 |
| US10213443B2 (en) | 2019-02-26 |
| EP2925293A1 (en) | 2015-10-07 |
| US20140147504A1 (en) | 2014-05-29 |
| DK2925293T3 (da) | 2017-11-06 |
| US9592246B2 (en) | 2017-03-14 |
| CN104902875B (zh) | 2018-04-03 |
| ZA201504369B (en) | 2017-01-25 |
| RU2015122786A (ru) | 2017-01-10 |
| US20170182071A1 (en) | 2017-06-29 |
| RU2639591C2 (ru) | 2017-12-21 |
| AU2013350941B2 (en) | 2018-04-26 |
| CN104902875A (zh) | 2015-09-09 |
| JP2016500095A (ja) | 2016-01-07 |
| EP2925293B1 (en) | 2017-08-02 |
| IL239022B (en) | 2020-11-30 |
| IL239022A0 (en) | 2015-07-30 |
| KR102235922B1 (ko) | 2021-04-05 |
| JP6444308B2 (ja) | 2018-12-26 |
| ES2645449T3 (es) | 2017-12-05 |
| NZ708824A (en) | 2019-01-25 |
| CA2895395C (en) | 2021-04-06 |
| SG11201504145PA (en) | 2015-07-30 |
| KR20150104102A (ko) | 2015-09-14 |
| BR112015012162B1 (pt) | 2021-02-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2925293T3 (pl) | Formulacje tetracykliny do stosowania miejscowego, ich przygotowanie i zastosowania | |
| IL289759A (en) | Formulations for local disinfection and their uses | |
| CO6831975A2 (es) | Inmunoconjugados, composiciones para prepararlos, métodos para prepararlos y uso | |
| SI3725778T1 (sl) | Formulacije enzalutamida | |
| DK3216448T3 (da) | Paraciticide orale veterinære sammensætninger omfattende systemisk-virkende aktivstoffer, fremgangsmåder og anvendelser deraf | |
| DK2903600T3 (da) | Virusholdig formulering og anvendelse deraf | |
| BR112015002738A2 (pt) | composto , e , composição farmacêutica | |
| HUE036755T2 (hu) | Antimikrobiális vegyületek, valamint ezek elõállítása és alkalmazása | |
| BR112014012005A2 (pt) | composições, métodos, formulação farmacêutica e artigo | |
| IL237287A0 (en) | Antibody compositions and their uses | |
| EP2893918A4 (en) | ORAL COMPOSITION | |
| EP2846781A4 (en) | PROLIPOSOMAL TESTOSTERONE FORMULATIONS | |
| DK2745849T3 (da) | Polydeoxyribonukleotidsammensætning og anvendelser deraf | |
| IL231444A0 (en) | Aniline derivativs, their preparation and their therapeutic application | |
| ZA201501124B (en) | Trans-clomiphene formulations and uses thereof | |
| IL233602A0 (en) | History of benzamide, their preparation and pharmaceutical preparations containing them | |
| DK2888100T3 (da) | Fremstillingsfremgangsmåde, fremstillingsform og anvendelse | |
| PT2908835T (pt) | Formulações estáveis | |
| DK2931042T3 (da) | Anthracyclinformuleringer | |
| IL280316B (en) | Bolaamphiphilic compounds, compositions and uses thereof | |
| DE112013002488T8 (de) | Vesikuläre Formulierungen, Kits und Verwendungen | |
| FI20136136A7 (fi) | Menetelmä kosmeettisten koostumusten valmistamiseksi, kosmeettiset koostumukset sekä niiden käyttö | |
| EP2945703A4 (en) | ALBU-BCHE FORMULATIONS, PREPARATION THEREOF AND USES THEREOF | |
| DK2900234T3 (da) | Kræft-kemoterapeutisk middel/formulering, fremstilling og anvendelse deraf | |
| BR112015001169A2 (pt) | polimorfo, uso do polimorfo, composição farmacêutica e uso para preparar o polimorfo |